Nature : Four technologies that could transform the treatment of blindness
A decade ago, clinicians had nothing to offer most people affected by retinal degeneration. Breakthroughs in genetics, bionics and stem-cell therapy are changing that.
“Blindness is one of the most life-altering conditions a person could experience,” says William Hauswirth, an ophthalmologist at the University of Florida in Gainesville. “Restoring useful vision would make an almost unimaginable improvement in quality of life.”
« French industry does not belong to the past » Agnès-Pannier Runacher
#LetsgoFrance 2019 Trophy “France that shines internationally”: Pixium Vision
The French start-up Pixium Vision’s Prima, a bionic vision system, the result of international collaboration, from Stanford to the prestigious European research organizations.
The innovators who advance France have followed their lucky stars! And they led them … to Station F for the 2nd edition of the #LetsgoFrance Trophies.
XX National Congress GIVRE 4-6 April 2019 Rome, Italy
Friday 5th April : IMPLANTS SESSION, STEM CELLS AND GENETICS (17:00-18:30)
PRIMA Clinical Study Update – Dr Yannick Le MER (Paris, France)
2019 KOL Event Meeting on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) – Short version
Three ophthalmology experts discuss PRIMA in advanced dry-AMD :
- Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”
- Pr. D. Palanker : “PRIMA inventor’s motivation”
- Pr. J-A. Sahel : “First in human study PRIMA in AMD”
2019 KOL Event Meeting on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) – Short version
Highlights
of the KOL meeting : Three ophthalmology experts discuss PRIMA in advanced
dry-AMD :
·
Pr.
F. Holz : “Real world unmet medical need : atrophic dry-AMD”
·
Pr. D. Palanker : “PRIMA inventor’s
motivation”
·
Pr.
J-A. Sahel : “First in human study PRIMA in AMD”
To have access to the Powerpoint presentation, please click on the title
2019 KOL Event Meeting on promising results with PRIMA : Long version
An update
on promising results with PRIMA in advanced dry-Age-related Macular
Degeneration (AMD) presented by three experts and thought leaders in
ophthalmology:
·
Pr.
F. Holz : “Real world unmet medical need : atrophic dry-AMD”
·
Pr. D. Palanker : “PRIMA inventor’s
motivation”
·
Pr.
J-A. Sahel : “First in human study with PRIMA in AMD”
Read the PDF »
2019 KOL Event Meeting on promising results with PRIMA : Long version
An update on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) presented by three experts and thought leaders in ophthalmology:
- Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”
- Pr. D. Palanker : “PRIMA inventor’s motivation”
- Pr. J-A. Sahel : “First in human study with PRIMA in AMD”